Bayer, a pharmaceutical and life sciences company, issued the following news release:. Bayer announced today that the Japanese Ministry of Health, Labour and Welfare has approved Jivi (R) for the prophylactic treatment of hemophilia A for adults and adolescents 12 years of age or older in Japan. Teruhisa Fujii, director of the Blood Transfusion Div
Contract notice: Denmark- Copenhagen: Pharmaceutical products. The tender number includes the following medicines: Tender no: 1, Atc code: L04ab05, Generic name: Certolizumab pegol, Dispensing form: Injection, Strength: 200 mg, Packing: Syringe/ pen, Unit value: 14 mg, Quantity in units: 211 668. Reference is made to the terms of the tender terms.
Albany, NY 09/21/2018 Transparency Market Research has published a new report titled, "Pulmonary Drug Delivery Devices Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 2026". North America and Europe are expected to dominate the global pulmonary drug delivery devices market in the next few years. Additional
Company: COMPETITIVE AGENCY OF KALININGRAD REGION. Address: Russian Federation, 236007, Kaliningrad region, Kaliningrad, UL D.DONSKOGO, HOUSE 1 Attn: Pisochnyuk Anna Alexandrovna Tel: 8-4012-599399 Fax: 8-4012-599028. The initial contract price: 300000.00 Russian Ruble Date and time of the deadline for submission of applications: 03.10. 2018 11:00.
Camurus announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use, CHMP, has adopted a positive opinion recommending approval of Buvidal prolonged-release solution for injection for treatment of opioid dependence in adults and adolescents from 16 years of age. "The excellent news that the CHMP recomme
By a News Reporter-Staff News Editor at Drug Week A new study on Drugs and Therapies- Drug Delivery Systems is now available. According to news reporting from Maharashtra, India, by NewsRx journalists, research stated, "Stimuli-responsive supramolecular assemblies of potential drug/guest molecules through non-covalent host-guest interaction have.
ALAMEDA- Exelixis, Inc. today announced that its partner Ipsen Biopharmaceuticals Canada Inc. received approval from Health Canada of CABOMETYX tablets for the treatment of adults with advanced renal cell carcinoma who have received prior vascular endothelial growth factor targeted therapy. 'The approval of CABOMETYX in Canada helps address a...
Exelixis, Inc. today announced that its partner Ipsen received a positive opinion from the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, for CABOMETYX tablets as a monotherapy for the treatment of hepatocellular carcinoma in adults who have been previously treated with sorafenib.
Albany, NY 09/21/2018 This report studies the global market size of Intranasal Drug Delivery in key regions like North America, Europe, Asia Pacific, Central& South America and Middle East& Africa, focuses on the consumption of Intranasal Drug Delivery in these regions. This research report categorizes the global Intranasal Drug Delivery mark
This report focuses on the global Nanotechnology Drug Delivery status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanotechnology Drug Delivery development in United States, Europe and Chin...
On September 20, IntelGenx signed a Letter of Intent with Tilray to enter into a world-wide agreement to produce cannabis-infused VersaFilm products. On Sep.18, the U.S. Drug Enforcement Administration approved the import of a pharmaceutical-grade medical cannabis product produced by Tilray into the United States for a clinical trial focused on...
By a News Reporter-Staff News Editor at Drug Week Researchers detail new data in Vascular Diseases and Conditions- Ischemia. According to news reporting from Kemerovo, Russia, by NewsRx journalists, research stated, "Liposomes have the potential to be used for drug delivery. The news correspondents obtained a quote from the research from the Rese
-Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it will be co-hosting a workshop with BASF Corporation entitled Revolutionary Then, Relevant Today: Lipid-Based Drug Delivery in Modern Pharmaceutical Development
SOMERSET, N.J.- Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it will be co-hosting a workshop with BASF Corporation entitled "Revolutionary Then, Relevant Today: Lipid-Based Drug Delivery in Modern Pharmace
This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies. This report focuses on the global Nanotechnology Drug Delivery status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanotechnology Dru
The leading players in the Nasal Drug Delivery Technology Market include Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Pfizer, Inc. (U.S.), AstraZeneca plc. (U.S.), AptarGroup (U.S.), an...
By a News Reporter-Staff News Editor at Drug Week Research findings on Drugs and Therapies- Drug Delivery Systems are discussed in a new report. According to news originating from Columbus, Ohio, by NewsRx correspondents, research stated, "The prolonged circulation time of nanoparticles in the blood is a prerequisite to realize a controlled and t
New Findings from Sardar Vallabhbhai National Institute of Technology in the Area of Drug Delivery Systems Reported. Funders for this research include Department of Science and Technology, Institute Research Grants, Council of Scientific and Industrial Research, American Clinical Neurophysiology Society, Australian Nuclear Science and Technology...
Otsuka Pharmaceutical Factory, Inc. announced that it has filed a patent infringement lawsuit against AY Pharmaceuticals Co., Ltd. and Yoshindo Inc. in Tokyo District Court on September 19, 2018, alleging that ONEPAL No. 1 Injection and ONEPAL No. 2 Injection manufactured and distributed by AY Pharmaceuticals and distributed by Yoshindo infringe OP
By a News Reporter-Staff News Editor at Angiogenesis Weekly According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors STEFANIC, Martin Friedrich; HILBERG, Frank; KAISER, Rolf; SHAPIRO, David, filed on May 1, 2018, was made available online on August 30, 2018. The assignee for this
Albany, NY 09/20/2018 Pulmonary drug delivery systems refer to the technologies that are used to treat diseases such as asthma, chronic obstructive pulmonary disease, and cystic fibrosis using pulmonary route of drug administration. However, the vendors of this market are expected to gain vast new opportunities in the emerging economies of As
Recent Research from Hong Kong Polytechnic University Highlight Findings in Drug Delivery Systems. According to news reporting out of Hong Kong, People's Republic of China, by NewsRx editors, research stated, "Conventional core- shell polymer nanoparticles usually exhibit a rapid release rate with their release kinetics mainly adjusted through chan
Report Summarizes Drug Delivery Systems Study Findings from Medical College of Wisconsin. According to news reporting out of Milwaukee, Wisconsin, by NewsRx editors, research stated, "Dendrimers are widely recognized as members of the fourth major architectural class of polymers after linear, cross-linked, and branched architectural types.
Reports from University of Glasgow Provide New Insights into Drug Delivery Systems. Financial supporters for this research include Royal Society, University of Glasgow, H2020 European Research Council. The news correspondents obtained a quote from the research from the University of Glasgow, "In contrast, the isoreticular analog linked by fumarate